Tradestie Institutional Equity Comparison Engine

PMI vs PRE โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-19 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

PMI Overall Edge

PMI Captures Institutional Edge (3โ€“1 Pillars ยท 6โ€“3 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Picard Medical, Inc. (PMI) driven by superior Valuation, Momentum & Technical, Options & Structure while PRE counters with relative strength in Growth & Margin. Fundamentally, PMI trades at N/M Forward P/E with -248.1% operating margin (+38.6% YoY revenue) versus PRE at N/M Forward P/E and -32.5% operating margin (+172.2% YoY). In options structure, PMI sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against PRE sits in BREAKDOWN (13th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner PMI
PMI N/M vs PRE N/M Fwd P/E
Growth & Margin Winner PRE
Op Margin -248.1% vs -32.5% ยท YoY +38.6% vs +172.2%
Momentum & Technical Winner PMI
1Y +107.2% vs -16.3% ยท 52W Pos 34% vs 6%
Options & Structure Winner PMI
UNCLASSIFIED (N/A IV) vs BREAKDOWN (13th %ile IV)
PMI NYSE American
Picard Medical, Inc.
Surgical & Medical Instruments & Apparatus
$6.30
-2.17% 1D
Market Cap $17.1M
1M Return -34.58%
1Y Return +107.24%
Forward P/E N/M
Unified AI Score
48.4 / 100 HOLD
Tech 39.0 Fund 45.0 Flow 50.0 Mom 50.0
PRE NASDAQ
Prenetics Global Limited Class A Ordinary Share
Laboratory Analytical Instruments
$10.31
-0.39% 1D
Market Cap $205.5M
1M Return -38.37%
1Y Return -16.28%
Forward P/E N/M
Unified AI Score
40.8 / 100 SELL
Tech 25.0 Fund 45.0 Flow 55.0 Mom 44.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: PMI +107.24% PRE -16.28% Spread: +164.31 pp (PMI Lead)

Pillar 3 Annualized Quarterly Run-Rate Revenue & Operating Margin Trajectory (USD-Normalized)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period PMI Revenue PRE Revenue PMI Op. Margin PRE Op. Margin Margin Edge
Q2 '25 $10M $50M -165.2% -70.0% PRE
Q3 '25 $0M $90M -293.8% -27.8% PRE
Q4 '25 $0M $150M -297.6% -35.9% PRE
Q1 '26 $0M $140M -392.3% -27.0% PRE

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: PMI (6) vs PRE (3)
Institutional Metric PMI PRE Criterion Row Winner
Market Capitalization Scale $17.1M $205.5M Larger Scale PRE
Trailing P/E Ratio Valuation 2.9x N/M Lower Multiple PMI
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth +38.6% +172.2% Higher Growth PRE
Operating Margin (TTM) Profitability -248.1% -32.5% Higher Margin PRE
Net Profit Margin Profitability 0.0% -32.6% Higher Margin PMI
Return on Equity (ROE) Capital Efficiency 0.0% -67.8% Higher ROE PMI
52-Week Range Position Momentum 34% ($0โ€“$18) 6% ($9โ€“$27) Stronger Trend PMI
Beta / 30D Volatility Risk Regime 54.06ฮฒ ยท 134% Vol 1.66ฮฒ ยท 141% Vol Lower Realized Risk PMI
Unified Institutional Score Composite Signal 48.4 / 100 (HOLD) 40.8 / 100 (SELL) Higher Composite PMI

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full PMI vs PRE Buy Guide
PMI UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live PMI Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
PRE BREAKDOWN
59d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 13th %ile
IV Regime Compressed (<25th %ile)
Live PRE Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither PMI nor PRE registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.